Unique ID issued by UMIN | UMIN000011328 |
---|---|
Receipt number | R000013220 |
Scientific Title | Comparison of blood pressure lowering effects of increasing dose of calcium channel blocker or adding diuretics in patients with insufficient blood pressure control with moderate dose of angiotensin receptor blocker and calcium channel blocker. |
Date of disclosure of the study information | 2013/08/01 |
Last modified on | 2016/02/01 15:15:25 |
Comparison of blood pressure lowering effects of increasing dose of calcium channel blocker or adding diuretics in patients with insufficient blood pressure control with moderate dose of angiotensin receptor blocker and calcium channel blocker.
Comparison of blood pressure lowering effects of increasing dose of calcium channel blocker or adding diuretics
Comparison of blood pressure lowering effects of increasing dose of calcium channel blocker or adding diuretics in patients with insufficient blood pressure control with moderate dose of angiotensin receptor blocker and calcium channel blocker.
Comparison of blood pressure lowering effects of increasing dose of calcium channel blocker or adding diuretics
Japan |
Hypertension
Cardiology |
Others
NO
To compare blood pressure lowering effects of increasing dose of calcium channel blocker or adding diuretics in patients with insufficient blood pressure control with moderate dose of angiotensin receptor blocker and calcium channel blocker.
Safety
Changes in clinic blood pressure and morning home blood pressure.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
Calcium channel blocker
Diuretic
Not applicable |
Not applicable |
Male and Female
Inclusion criteria:Male or female patients with essential hypertension whose clinic and/or home blood pressure remain above goal blood pressures indicated by the 2009 guidelines by Japan Hypertension Society despite treatment with moderate amount of angiotensin receptor blocker and calcium channel blocker.
1) Patients receiving angiotensin converting enzyme inhibitor,renin inhibitor or diuretics.
2) Patients considered not feasible to receive diuretics or 10mg of amlodipine. 3) Patents with poor compliance to treatment.
4) Shift workers.
5) Patients on hemodialysis.
170
1st name | |
Middle name | |
Last name | Toshio Kushiro |
Surugadai Nihon University Hospital
Cardiology
1-8-13 Kandasurgadai, Chiyodaku, Tokyo, Japan
+81-03-3293-1711
tanishigem@yahoo.co.jp
1st name | |
Middle name | |
Last name | Toshio Kushiro |
Surugadai Nihon University Hospital
Cardiology
1-8-13 Kandasurgadai, Chiyodaku, Tokyo, Japan
03-3293-1711
tanishigem@yahoo.co.jp
Toshio Kushiro
Surugadai Nihon University Hospital
Self funding
NO
2013 | Year | 08 | Month | 01 | Day |
Unpublished
Completed
2013 | Year | 03 | Month | 01 | Day |
2013 | Year | 08 | Month | 01 | Day |
2015 | Year | 10 | Month | 30 | Day |
2013 | Year | 07 | Month | 31 | Day |
2016 | Year | 02 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013220
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |